Invention Application
- Patent Title: EX VIVO ANTIBODY PRODUCTION
-
Application No.: US16575518Application Date: 2019-09-19
-
Publication No.: US20200149007A1Publication Date: 2020-05-14
- Inventor: PAULA MARIA WILHELMINA VAN HELDEN , Mark Jeroen KWAKKENBOS , Hergen Spits , Tim Beaumont
- Applicant: AIMM THERAPEUTICS B.V.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@a4cdbc8
- Main IPC: C12N5/0781
- IPC: C12N5/0781 ; C12P21/00 ; C07K16/10 ; C07K16/00 ; C12N15/86
Abstract:
The present invention provides means and methods for producing improved ex vivo B cell cultures with a short doubling time.
Public/Granted literature
- US12084681B2 Ex vivo antibody production Public/Granted day:2024-09-10
Information query
